Acquisitions and desire for minimally invasive implant devices are set to boost growth of textiles in medical implants, says a recent analysis of the biomedical textiles market in the US. Strong growth is occurring across all segments due to new product launches and product enhancements carried out by device manufacturers for differentiating themselves.

The Analysis of Biomedical Textiles Market in US, a new analysis from Frost & Sullivan’s visionary science growth partnership service program states that market participants are investing in patients’ needs through broader product portfolios, minimally invasive surgical procedures and technology that helps patients recover faster to drive the growth of textiles in medical implants. Acquisitions of peer companies by market leaders to gain access to technology and geographic expansion are also contributing to this growth.

“Medical implants based on polymer and biologics such as Poly Ether Ether Ketone (PEEK), Polytetrafluoroethylene (PTFE), Polyester, Polyethylene and Polypropylene for better strength, flexibility and biocompatibility are trends delivering tremendous growth opportunities across this sector,” said Arun Ramesh, Frost & Sullivan visionary innovation industry analyst.

The adoption of device implants is gaining momentum among patient populations globally and is driving implant device technology, including novel biomaterials. Innovation and testing (in vivo and in-vitro) of biodegradable materials used in medical implants limit the need for another surgery, support faster recovery and prolong quality life for patients.

The expanding geriatric population, increasing prevalence of chronic diseases and consumer preference for minimally invasive surgery are stimulating product advances as medical device players rethink their application and market segment strategies, says the analysis. (KD)